About Hospital Universitario Virgen del Rocio; Servicio de Hematologia
Hospital Universitario Virgen del Rocío is the name of the complex of hospitals located in the center of Sevilla, and one of the most important hospitals in the South of Spain, being the biggest hospital in the region. It is managed by the public company "Servicio Andaluz de Salud".
There are 1,251 beds in Hospital Universitario Virgen del Rocio; Servicio de Hematologia.
Clinical Trials at Hospital Universitario Virgen del Rocio; Servicio de Hematologia
During the past decade, Hospital Universitario Virgen del Rocio; Servicio de Hematologia conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia"
#1 collaborator was "Chugai Pharmaceutical" with 4 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital Universitario Virgen del Rocio; Servicio de Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia" are
"Hemophilia A" (7 trials), "Sickle Cell Disease" (2 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials), "B-cell Lymphoma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Virgen del Rocio; Servicio de Hematologia
Most popular intervention types in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia" are "Drug" (22 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Emicizumab" (7 trials), "Placebo" (6 trials), "Obinutuzumab" (5 trials), "Cyclophosphamide" (4 trials) and "Rituximab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Virgen del Rocio; Servicio de Hematologia
The vast majority of trials in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia" are
22 trials for "All" genders.
Clinical Trials Status at Hospital Universitario Virgen del Rocio; Servicio de Hematologia
Currently, there are NaN active trials in "Hospital Universitario Virgen del Rocio; Servicio de Hematologia".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Hospital Universitario Virgen del Rocio; Servicio de Hematologia,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Virgen del Rocio; Servicio de Hematologia, 5 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".